GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders.

Gaucher disease Parkinson disease allosteric chaperones iminosugars lysosomal storage disorders pharmacological chaperones

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
02 Jul 2022
Historique:
received: 10 06 2022
revised: 28 06 2022
accepted: 29 06 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Pharmaceutical chaperones (PCs) are small compounds able to bind and stabilize misfolded proteins, allowing them to recover their native folding and thus their biological activity. In particular, lysosomal storage disorders (LSDs), a class of metabolic disorders due to genetic mutations that result in misfolded lysosomal enzymes, can strongly benefit from the use of PCs able to facilitate their translocation to the lysosomes. This results in a recovery of their catalytic activity. No PC for the GCase enzyme (lysosomal acid-β-glucosidase, or glucocerebrosidase) has reached the market yet, despite the importance of this enzyme not only for Gaucher disease, the most common LSD, but also for neurological disorders, such as Parkinson's disease. This review aims to describe the efforts made by the scientific community in the last 7 years (since 2015) in order to identify new PCs for the GCase enzyme, which have been mainly identified among glycomimetic-based compounds.

Identifiants

pubmed: 35890122
pii: ph15070823
doi: 10.3390/ph15070823
pmc: PMC9325019
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Università di Firenze and Fondazione CR Firenze ("Bando congiunto per il finanziamento di pro-getti competitivi sulle malattie neurodegenerative 2018")
ID : Acronym: MuTaParGa
Organisme : Regione Toscana (Bando Salute 2018)
ID : Acronym: LysoLate

Références

Org Biomol Chem. 2016 Oct 7;14(37):8670-3
pubmed: 27604065
Autophagy. 2019 Jan;15(1):113-130
pubmed: 30160596
Pharm Pat Anal. 2013 Jan;2(1):109-24
pubmed: 24236974
Ann Neurol. 2016 Nov;80(5):766-775
pubmed: 27859541
Brain. 2015 Sep;138(Pt 9):2648-58
pubmed: 26117366
Bioorg Chem. 2019 May;86:652-664
pubmed: 30825709
J Med Chem. 2015 Nov 12;58(21):8315-59
pubmed: 26200936
J Org Chem. 2011 Oct 7;76(19):7757-68
pubmed: 21830816
J Cell Sci. 2019 Jan 16;132(2):
pubmed: 30651381
Chembiochem. 2012 Mar 19;13(5):661-4
pubmed: 22344719
Chembiochem. 2014 Jun 16;15(9):1239-51
pubmed: 24807298
Molecules. 2021 Sep 27;26(19):
pubmed: 34641408
Lancet Neurol. 2006 Jun;5(6):525-35
pubmed: 16713924
FEBS J. 2006 Sep;273(17):4082-92
pubmed: 16934036
Carbohydr Res. 2016 Jun 24;429:98-104
pubmed: 27063390
Angew Chem Int Ed Engl. 2021 Mar 1;60(10):5436-5442
pubmed: 33238058
J Am Chem Soc. 2007 Jan 24;129(3):635-44
pubmed: 17227027
Angew Chem Int Ed Engl. 2015 Sep 28;54(40):11696-700
pubmed: 26386364
Mov Disord. 2021 May;36(5):1070-1085
pubmed: 33219714
FEBS J. 2007 Oct;274(19):4944-50
pubmed: 17894779
Molecules. 2020 Jul 09;25(14):
pubmed: 32660097
J Biol Chem. 2007 Sep 28;282(39):29052-29058
pubmed: 17666401
Expert Opin Ther Pat. 2011 Jun;21(6):885-903
pubmed: 21457079
Chem Commun (Camb). 2016 Apr 25;52(32):5497-515
pubmed: 27043200
Bioorg Chem. 2020 May;98:103740
pubmed: 32200326
N Engl J Med. 2009 Oct 22;361(17):1651-61
pubmed: 19846850
Curr Top Med Chem. 2009;9(1):34-57
pubmed: 19199995
Bioorg Med Chem. 2008 Aug 1;16(15):7330-6
pubmed: 18595718
Eur J Med Chem. 2015 Jan 27;90:258-66
pubmed: 25461326
Chemistry. 2014 Sep 8;20(37):11616-28
pubmed: 25081380
J Biol Chem. 2009 Aug 28;284(35):23502-16
pubmed: 19578116
Future Med Chem. 2014 Jun;6(9):1031-45
pubmed: 25068986
Org Biomol Chem. 2018 Nov 14;16(44):8604-8612
pubmed: 30378631
ACS Med Chem Lett. 2019 Feb 08;10(4):621-626
pubmed: 30996807
Chembiochem. 2022 Jun 3;23(11):e202200077
pubmed: 35322924
Biochemistry. 2006 Feb 28;45(8):2629-35
pubmed: 16489756
Org Biomol Chem. 2016 Jan 28;14(4):1473-84
pubmed: 26690983
Chembiochem. 2015 Sep 21;16(14):2054-64
pubmed: 26376302
J Neurochem. 2016 Oct;139 Suppl 1:198-215
pubmed: 26860955
ACS Chem Biol. 2017 Jul 21;12(7):1830-1841
pubmed: 28485919
Expert Opin Ther Targets. 2020 Apr;24(4):287-294
pubmed: 32106725
Synapse. 2017 Jul;71(7):
pubmed: 28295625
Hum Mol Genet. 2016 Jul 1;25(13):2712-2727
pubmed: 27162249
J Med Chem. 2012 Aug 9;55(15):6857-65
pubmed: 22762530
J Med Chem. 2017 Mar 9;60(5):1829-1842
pubmed: 28171725
J Med Chem. 2013 Apr 11;56(7):2705-25
pubmed: 23363020
Sci Rep. 2016 Aug 19;6:31380
pubmed: 27539639
Org Biomol Chem. 2014 Apr 14;12(14):2289-301
pubmed: 24589885
Chem Commun (Camb). 2020 May 14;56(39):5207-5222
pubmed: 32322844
Arch Neurol. 2010 Dec;67(12):1464-72
pubmed: 20697033
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15428-33
pubmed: 12434014
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
Chembiochem. 2014 Jan 24;15(2):309-19
pubmed: 24375964
Future Med Chem. 2015;7(4):527-46
pubmed: 25875877
Chembiochem. 2009 Nov 23;10(17):2780-92
pubmed: 19830760
JAMA Neurol. 2020 Apr 1;77(4):427-434
pubmed: 31930374
Front Cell Dev Biol. 2020 May 19;8:271
pubmed: 32509770
Chembiochem. 2006 Sep;7(9):1356-9
pubmed: 16871601
Angew Chem Int Ed Engl. 2005 Dec 1;44(45):7450-3
pubmed: 16231389
Neurotherapeutics. 2014 Oct;11(4):840-56
pubmed: 25037721
Eur J Med Chem. 2020 Apr 15;192:112173
pubmed: 32146376
Chemistry. 2017 Jul 6;23(38):9022-9025
pubmed: 28548311
Biochem Biophys Res Commun. 2015 Feb 20;457(4):561-6
pubmed: 25600808
ChemMedChem. 2017 Apr 6;12(7):483-486
pubmed: 28328014
Arch Biochem Biophys. 1964 Jul 20;106:252-8
pubmed: 14217166
Blood Cells Mol Dis. 2013 Feb;50(2):141-5
pubmed: 23158495
Org Biomol Chem. 2020 Oct 14;18(39):7852-7861
pubmed: 32975266
EMBO Mol Med. 2009 Aug;1(5):268-79
pubmed: 20049730
Org Biomol Chem. 2016 Jan 21;14(3):1039-48
pubmed: 26633162
Org Biomol Chem. 2017 May 3;15(17):3681-3705
pubmed: 28401966
Chem Rec. 2020 Jan;20(1):10-22
pubmed: 30993894
J Neurosci. 2016 Jul 13;36(28):7441-52
pubmed: 27413154
Bioorg Med Chem. 2014 Apr 15;22(8):2435-41
pubmed: 24657053
Future Med Chem. 2013 Apr;5(5):573-90
pubmed: 23573974
Molecules. 2018 Apr 17;23(4):
pubmed: 29673163
Int J Mol Sci. 2020 Jan 13;21(2):
pubmed: 31940970
J Am Chem Soc. 2018 May 9;140(18):5914-5924
pubmed: 29676907
BMC Neurol. 2019 Feb 9;19(1):20
pubmed: 30738426
Chem Sci. 2018 Jan 10;9(7):1740-1752
pubmed: 29719681
Brain. 2014 Mar;137(Pt 3):834-48
pubmed: 24477431
Molecules. 2019 Jan 19;24(2):
pubmed: 30669468
PLoS One. 2012;7(1):e29861
pubmed: 22272254
Brain Dev. 2013 Apr;35(4):317-22
pubmed: 22682976
Chem Commun (Camb). 2014 Nov 25;50(91):14253-6
pubmed: 25283380
Curr Opin Struct Biol. 2022 Feb;72:267-278
pubmed: 34999558
Blood Cells Mol Dis. 2013 Feb;50(2):134-7
pubmed: 23085429
Neuron. 2017 Feb 22;93(4):737-746
pubmed: 28231462
Nat Prod Rep. 2017 Jan 4;34(1):62-89
pubmed: 27782262
J Org Chem. 2013 Nov 1;78(21):10968-77
pubmed: 24083620
Sci Transl Med. 2019 Oct 16;11(514):
pubmed: 31619543
Int J Mol Med. 2013 Jan;31(1):11-20
pubmed: 23165354
Eur J Med Chem. 2016 Oct 4;121:880-891
pubmed: 26361824
Nat Rev Dis Primers. 2018 Oct 1;4(1):27
pubmed: 30275469

Auteurs

Macarena Martínez-Bailén (M)

Dipartimento di Chimica "Ugo Schiff" (DICUS), Università degli Studi di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.
Glycosystems Laboratory, Instituto de Investigaciones Químicas (IIQ), CSIC-Universidad de Sevilla, Av. Américo Vespucio 49, 41092 Sevilla, Spain.

Francesca Clemente (F)

Dipartimento di Chimica "Ugo Schiff" (DICUS), Università degli Studi di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.

Camilla Matassini (C)

Dipartimento di Chimica "Ugo Schiff" (DICUS), Università degli Studi di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.

Francesca Cardona (F)

Dipartimento di Chimica "Ugo Schiff" (DICUS), Università degli Studi di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.

Classifications MeSH